Europe's health & life sciences magazine launching on 12 October 2026. Four issues a year, in print. For innovators, health systems, policymakers, healthcare professionals, investors, patient organisations, and more.
Issue 01 - Counting on Europe - Autumn 2026 now available!
Reporting on health and life sciences in Europe for Rapporteur (Euractiv), EU Perspectives, European Biotechnology Magazine and APM Market Access.
Commissioned writing and editing for organisations in health and life sciences. Interviews, features, reports, and the editing that makes them shine.
EU PERSPECTIVES - Artificial intelligence, better care and heatwave preparedness will shape the EU's health agenda in 2027. A new AI blueprint will cover five sectors, including health, but no new health legislation is planned, with Brussels focusing instead on proposals already on the table. Read more
EU PERSPECTIVES - Actithera, a US start-up developing radiation-based cancer drugs, raised most of its $75.5m from European investors and runs its labs in Oslo. Yet it will treat its first patients in Australia. Its founder Andreas Goutopoulos told EU Perspectives that Europe makes early trials too hard to start. Read more
EU PERSPECTIVES - The WHO will soon open its first global rare disease plan for public comment, with patient groups expecting just 30 days to respond. They want Europe's 18-priority blueprint to help mould it. Read more
EU PERSPECTIVES - A European company is developing a device that could help doctors better manage heart failure. Yet, US patients will get it first. Its CEO says in an interview that the EU's reimbursement system is to blame. Read more
